vs

Side-by-side financial comparison of Ingersoll Rand (IR) and Kimberly-Clark (KMB). Click either name above to swap in a different company.

Kimberly-Clark is the larger business by last-quarter revenue ($4.2B vs $2.1B, roughly 2.0× Ingersoll Rand). Kimberly-Clark runs the higher net margin — 16.2% vs 12.7%, a 3.5% gap on every dollar of revenue. On growth, Ingersoll Rand posted the faster year-over-year revenue change (10.1% vs 2.7%). Over the past eight quarters, Ingersoll Rand's revenue compounded faster (11.9% CAGR vs -9.0%).

Ingersoll Rand Inc. is an American multinational company that provides flow creation and industrial products. The company was formed in February 2020 through the spinoff of the industrial segment of Ingersoll-Rand plc and its merger with Gardner Denver. Its products are sold under more than 40 brands across all major global markets.

Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.

IR vs KMB — Head-to-Head

Bigger by revenue
KMB
KMB
2.0× larger
KMB
$4.2B
$2.1B
IR
Growing faster (revenue YoY)
IR
IR
+7.5% gap
IR
10.1%
2.7%
KMB
Higher net margin
KMB
KMB
3.5% more per $
KMB
16.2%
12.7%
IR
Faster 2-yr revenue CAGR
IR
IR
Annualised
IR
11.9%
-9.0%
KMB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IR
IR
KMB
KMB
Revenue
$2.1B
$4.2B
Net Profit
$266.1M
$675.0M
Gross Margin
42.6%
36.8%
Operating Margin
18.7%
18.1%
Net Margin
12.7%
16.2%
Revenue YoY
10.1%
2.7%
Net Profit YoY
15.8%
17.3%
EPS (diluted)
$0.67
$2.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IR
IR
KMB
KMB
Q1 26
$4.2B
Q4 25
$2.1B
$3.3B
Q3 25
$2.0B
$4.2B
Q2 25
$1.9B
$4.2B
Q1 25
$1.7B
$4.8B
Q4 24
$1.9B
$4.9B
Q3 24
$1.9B
$5.0B
Q2 24
$1.8B
$5.0B
Net Profit
IR
IR
KMB
KMB
Q1 26
$675.0M
Q4 25
$266.1M
$499.0M
Q3 25
$244.1M
$446.0M
Q2 25
$-115.3M
$509.0M
Q1 25
$186.5M
$567.0M
Q4 24
$229.8M
$447.0M
Q3 24
$221.6M
$907.0M
Q2 24
$185.0M
$544.0M
Gross Margin
IR
IR
KMB
KMB
Q1 26
36.8%
Q4 25
42.6%
37.7%
Q3 25
43.7%
36.0%
Q2 25
43.7%
35.0%
Q1 25
44.6%
35.8%
Q4 24
42.9%
34.0%
Q3 24
43.8%
36.0%
Q2 24
43.9%
36.0%
Operating Margin
IR
IR
KMB
KMB
Q1 26
18.1%
Q4 25
18.7%
11.2%
Q3 25
19.2%
15.0%
Q2 25
4.0%
14.2%
Q1 25
17.6%
15.9%
Q4 24
20.0%
11.1%
Q3 24
19.1%
23.3%
Q2 24
15.1%
13.0%
Net Margin
IR
IR
KMB
KMB
Q1 26
16.2%
Q4 25
12.7%
15.1%
Q3 25
12.5%
10.7%
Q2 25
-6.1%
12.2%
Q1 25
10.9%
11.7%
Q4 24
12.1%
9.1%
Q3 24
11.9%
18.3%
Q2 24
10.2%
10.8%
EPS (diluted)
IR
IR
KMB
KMB
Q1 26
$2.00
Q4 25
$0.67
$1.50
Q3 25
$0.61
$1.34
Q2 25
$-0.29
$1.53
Q1 25
$0.46
$1.70
Q4 24
$0.57
$1.34
Q3 24
$0.54
$2.69
Q2 24
$0.45
$1.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IR
IR
KMB
KMB
Cash + ST InvestmentsLiquidity on hand
$1.2B
$542.0K
Total DebtLower is stronger
$4.8B
$6.5M
Stockholders' EquityBook value
$10.1B
$1.9M
Total Assets
$18.3B
$17.2M
Debt / EquityLower = less leverage
0.47×
3.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IR
IR
KMB
KMB
Q1 26
$542.0K
Q4 25
$1.2B
$688.0M
Q3 25
$1.2B
$617.0M
Q2 25
$1.3B
$634.0M
Q1 25
$1.6B
$563.0M
Q4 24
$1.5B
$1.0B
Q3 24
$1.4B
$1.1B
Q2 24
$1.1B
$1.2B
Total Debt
IR
IR
KMB
KMB
Q1 26
$6.5M
Q4 25
$4.8B
$6.5B
Q3 25
$4.8B
$6.5B
Q2 25
$4.8B
$6.5B
Q1 25
$4.8B
$6.5B
Q4 24
$4.8B
$6.9B
Q3 24
$4.8B
$6.9B
Q2 24
$4.8B
$7.2B
Stockholders' Equity
IR
IR
KMB
KMB
Q1 26
$1.9M
Q4 25
$10.1B
$1.5B
Q3 25
$10.1B
$1.3B
Q2 25
$10.1B
$1.3B
Q1 25
$10.5B
$1.1B
Q4 24
$10.2B
$840.0M
Q3 24
$10.3B
$1.3B
Q2 24
$10.0B
$1.1B
Total Assets
IR
IR
KMB
KMB
Q1 26
$17.2M
Q4 25
$18.3B
$17.1B
Q3 25
$18.2B
$16.9B
Q2 25
$18.1B
$16.8B
Q1 25
$18.4B
$16.3B
Q4 24
$18.0B
$16.5B
Q3 24
$18.2B
$17.2B
Q2 24
$17.8B
$17.3B
Debt / Equity
IR
IR
KMB
KMB
Q1 26
3.38×
Q4 25
0.47×
4.31×
Q3 25
0.47×
4.86×
Q2 25
0.47×
5.09×
Q1 25
0.45×
5.89×
Q4 24
0.47×
8.18×
Q3 24
0.47×
5.36×
Q2 24
0.48×
6.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IR
IR
KMB
KMB
Operating Cash FlowLast quarter
$499.0M
Free Cash FlowOCF − Capex
$461.5M
FCF MarginFCF / Revenue
22.1%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
1.88×
TTM Free Cash FlowTrailing 4 quarters
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IR
IR
KMB
KMB
Q1 26
Q4 25
$499.0M
$972.0M
Q3 25
$354.6M
$708.0M
Q2 25
$245.7M
$770.0M
Q1 25
$256.4M
$327.0M
Q4 24
$526.2M
$817.0M
Q3 24
$404.0M
$958.0M
Q2 24
$304.9M
$1.0B
Free Cash Flow
IR
IR
KMB
KMB
Q1 26
Q4 25
$461.5M
$575.0M
Q3 25
$325.5M
$368.0M
Q2 25
$210.4M
$573.0M
Q1 25
$222.7M
$123.0M
Q4 24
$490.9M
$608.0M
Q3 24
$374.3M
$798.0M
Q2 24
$283.1M
$863.0M
FCF Margin
IR
IR
KMB
KMB
Q1 26
Q4 25
22.1%
17.5%
Q3 25
16.6%
8.9%
Q2 25
11.1%
13.8%
Q1 25
13.0%
2.5%
Q4 24
25.9%
12.3%
Q3 24
20.1%
16.1%
Q2 24
15.7%
17.2%
Capex Intensity
IR
IR
KMB
KMB
Q1 26
Q4 25
1.8%
12.1%
Q3 25
1.5%
8.2%
Q2 25
1.9%
4.7%
Q1 25
2.0%
4.2%
Q4 24
1.9%
4.2%
Q3 24
1.6%
3.2%
Q2 24
1.2%
3.1%
Cash Conversion
IR
IR
KMB
KMB
Q1 26
Q4 25
1.88×
1.95×
Q3 25
1.45×
1.59×
Q2 25
1.51×
Q1 25
1.37×
0.58×
Q4 24
2.29×
1.83×
Q3 24
1.82×
1.06×
Q2 24
1.65×
1.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IR
IR

Transferred At Point In Time$1.5B71%
Transferred Over Time$193.0M9%
Precision And Science Technologies Segment$183.1M9%
Acquisitions In2024$175.6M8%
Acquisitions In2025$70.8M3%

KMB
KMB

NA$2.7B64%
IPC$1.5B36%

Related Comparisons